Bergrem H, Grøttum P, Rugstad H E
Eur J Clin Pharmacol. 1983;24(3):415-9. doi: 10.1007/BF00610064.
The pharmacokinetics of prednisolone after oral and intravenous administration of 10 and 20 mg have been studied. Serum protein binding of prednisolone was also measured after the i.v. injections. The bioavailability after oral administration was 84.5% after 10 mg and 77.6% after 20 mg (p greater than 0.05). Dose dependent pharmacokinetics were found, the VDss and Clt being significantly larger (p less than 0.01) after 20 mg i.v. than after 10 mg i.v. The protein binding of prednisolone in all subjects was non-linear, and is the most likely cause of the dose dependent pharmacokinetics, as there was no dose dependent variation in elimination half-time.
研究了口服和静脉注射10毫克及20毫克泼尼松龙后的药代动力学。静脉注射后还测定了泼尼松龙的血清蛋白结合率。口服给药后,10毫克剂量的生物利用度为84.5%,20毫克剂量的生物利用度为77.6%(p>0.05)。发现存在剂量依赖性药代动力学,静脉注射20毫克后的稳态分布容积(VDss)和总清除率(Clt)显著大于静脉注射10毫克后(p<0.01)。所有受试者中泼尼松龙的蛋白结合呈非线性,这很可能是剂量依赖性药代动力学的原因,因为消除半衰期不存在剂量依赖性变化。